UK alone are stocking up on 60m doses at GBP 660m.
http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/5858430/GSK-in-line-for-1.3bn-swine-flu-booster.html
http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/5889003/Glaxo-to-have-swine-flu-vaccine-by-September.html
GSK are likely going to have to ramp up production to relatively phenomenal numbers to meet future global demand IMO.
This can only send Biota into orbit!
Next, LANI and then some.....
Does anyone know if GSK have any rights to LANI ?
Does the pharma partner in Japan (2nd largest pharma in Japan) have rights to LANI ?
Thoughts ?
- Forums
- ASX - By Stock
- BTA
- please explain
please explain, page-4
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)